{"id":"https://openalex.org/W4394802202","doi":"https://doi.org/10.1097/01.ju.0001008572.33286.63.09","title":"PD09-09 ROLE OF TUMOR MICROENVIRONMENT DERIVED NRG1 IN ANDROGEN RESISTANCE: IMPLICATIONS FOR A NOVEL PROSTATE CANCER TREATMENT STRATEGY","display_name":"PD09-09 ROLE OF TUMOR MICROENVIRONMENT DERIVED NRG1 IN ANDROGEN RESISTANCE: IMPLICATIONS FOR A NOVEL PROSTATE CANCER TREATMENT STRATEGY","publication_year":2024,"publication_date":"2024-04-15","ids":{"openalex":"https://openalex.org/W4394802202","doi":"https://doi.org/10.1097/01.ju.0001008572.33286.63.09"},"language":"en","primary_location":{"id":"doi:10.1097/01.ju.0001008572.33286.63.09","doi":"https://doi.org/10.1097/01.ju.0001008572.33286.63.09","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ju.0001008572.33286.63.09","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026037697","display_name":"Brian M. Shinder","orcid":"https://orcid.org/0000-0001-8021-2414","observed_orcids":["https://orcid.org/0000-0001-8021-2414"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian Shinder","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904407","display_name":"Ninghui Mao","orcid":"https://orcid.org/0000-0003-1605-9608","observed_orcids":["https://orcid.org/0000-0003-1605-9608"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ninghui Mao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024562035","display_name":"Zeda Zhang","orcid":"https://orcid.org/0000-0002-7225-534X","observed_orcids":["https://orcid.org/0000-0002-7225-534X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zeda Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034963668","display_name":"Charles L. Sawyers","orcid":"https://orcid.org/0000-0003-4955-6475","observed_orcids":["https://orcid.org/0000-0003-4955-6475"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles L. Sawyers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5042883465","display_name":"Brett Stewart Carver","orcid":"https://orcid.org/0000-0001-5165-3544","observed_orcids":["https://orcid.org/0000-0001-5165-3544"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brett S. Carver","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.2905,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.54041568,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":94},"biblio":{"volume":"211","issue":"5S","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuregulin-1","display_name":"neuregulin-1","score":0.9179999828338623},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7839999794960022},{"id":"https://openalex.org/keywords/androgen-resistance","display_name":"androgen resistance","score":0.9279999732971191},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.8949999809265137},{"id":"https://openalex.org/keywords/androgen-receptor-inhibition","display_name":"androgen receptor inhibition","score":0.746999979019165},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9620000123977661},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.8140000104904175},{"id":"https://openalex.org/keywords/pten","display_name":"PTEN","score":0.7099999785423279},{"id":"https://openalex.org/keywords/pten-loss","display_name":"PTEN loss","score":0.4490000009536743},{"id":"https://openalex.org/keywords/fibroblasts","display_name":"fibroblasts","score":0.5320000052452087},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.671999990940094},{"id":"https://openalex.org/keywords/antiandrogen-therapy","display_name":"antiandrogen therapy","score":0.4099999964237213}],"concepts":[{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.7816128730773926},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.679039478302002},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6298515200614929},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6259198784828186},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.5937753915786743},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5267890095710754},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.5132322311401367},{"id":"https://openalex.org/C2778560701","wikidata":"https://www.wikidata.org/wiki/Q14914188","display_name":"Neuregulin 1","level":3,"score":0.5044251680374146},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5008764266967773},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.49463340640068054},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.44369128346443176},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42852017283439636},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3856548070907593},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33816230297088623},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3151945471763611},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2501124143600464},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.17834004759788513},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.15300604701042175},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.10388454794883728},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.ju.0001008572.33286.63.09","doi":"https://doi.org/10.1097/01.ju.0001008572.33286.63.09","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ju.0001008572.33286.63.09","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4392821309","https://openalex.org/W4417297673","https://openalex.org/W3048711265","https://openalex.org/W4251371956","https://openalex.org/W3043502623","https://openalex.org/W7133212782","https://openalex.org/W3048217615","https://openalex.org/W4282932390","https://openalex.org/W4403952395","https://openalex.org/W3213451896"],"abstract_inverted_index":{"You":[0],"have":[1],"accessJournal":[2],"of":[3,111,159,163,260,292,350,464,495,554,581,590,594],"UrologyProstate":[4],"Cancer:":[5],"Basic":[6],"Research":[7],"&":[8,617],"Pathophysiology":[9],"II":[10],"(PD09)1":[11],"May":[12],"2024PD09-09":[13],"ROLE":[14],"OF":[15],"TUMOR":[16],"MICROENVIRONMENT":[17],"DERIVED":[18],"NRG1":[19,147,160,241,328,390,415,448,479,496],"IN":[20],"ANDROGEN":[21],"RESISTANCE:":[22],"IMPLICATIONS":[23],"FOR":[24],"A":[25],"NOVEL":[26],"PROSTATE":[27],"CANCER":[28],"TREATMENT":[29],"STRATEGY":[30],"Brian":[31,44,630],"Shinder,":[32],"Ninghui":[33,48,637],"Mao,":[34],"Zeda":[35,52,644],"Zhang,":[36],"Charles":[37,56,651],"L.":[38,57,59,652],"Sawyers,":[39],"and":[40,62,88,109,128,180,196,226,266,269,281,341,359,396,432,453,481,529,573,584,607,625],"Brett":[41,63,659],"S.":[42,64,66,660],"Carver":[43,67,661],"ShinderBrian":[45],"Shinder":[46,631],",":[47,51,55,61],"MaoNinghui":[49],"Mao":[50,638],"ZhangZeda":[53],"Zhang":[54,645],"SawyersCharles":[58],"Sawyers":[60,653],"CarverBrett":[65],"View":[68],"All":[69,668],"Author":[70,628],"Informationhttps://doi.org/10.1097/01.JU.0001008572.33286.63.09AboutPDF":[71],"ToolsAdd":[72],"to":[73,86,124,150,187,215,256,331,357,387,399,413,442,455,508,519],"favoritesDownload":[74],"CitationsTrack":[75],"CitationsPermissionsReprints":[76],"ShareFacebookLinked":[77],"InTwitterEmail":[78],"Abstract":[79],"INTRODUCTION":[80],"AND":[81],"OBJECTIVE:":[82],"It":[83],"is":[84,208,221,499],"crucial":[85],"identify":[87],"target":[89],"the":[90,107,125,139,202,247,290,337,348,378,406,429,505,534,582,591],"mechanisms":[91],"by":[92,370,501,560,602,620,634,641,648,656,664],"which":[93,207],"prostate":[94,541],"cancer":[95,484],"(PCa)":[96],"cells":[97,229,283,354,383,404,503],"persist":[98],"despite":[99],"AR":[100,151,456],"inhibition.":[101,152],"Prior":[102],"work":[103,557],"has":[104],"shown":[105],"that":[106,156,447],"upregulation":[108],"secretion":[110],"stromal-derived":[112],"growth":[113,132,361,395,426],"factor":[114],"neuregulin":[115],"1":[116],"(NRG1)":[117],"activates":[118],"PI3K-AKT":[119,466],"signaling":[120,165,262,335,467],"through":[121,511],"its":[122],"binding":[123],"HER2/HER3":[126,164],"receptor":[127],"promotes":[129,449],"PCa":[130,450,461,470],"cell":[131,199,339,360,394,451,472],"during":[133],"antiandrogen":[134],"treatment.":[135,271],"Here,":[136],"we":[137,154,516],"determine":[138],"clinical":[140,168,551],"context":[141],"where":[142],"this":[143,342,367,577,635,642,649,657,665],"tumor":[144,425,506],"microenvironment":[145,507],"derived":[146,201,245],"impacts":[148],"response":[149,398],"Additionally,":[153],"show":[155,446],"selective":[157],"inhibition":[158,457],"mediated":[161,493],"activation":[162,259],"with":[166,238,265,298,326,372,375,405,483],"a":[167,469,491,561],"grade":[169],"bispecific":[170],"humanized":[171],"IgG1,":[172],"zenocutuzumab":[173,268,376,400],"(Zeno,":[174],"MCLA-128),":[175],"in":[176,178,181,289,336,347,419,427,458,468,504,525,527,530,533,576],"both":[177,264,428,477,526],"vitro":[179,528],"vivo":[182,420,531],"models":[183,532],"can":[184,213],"overcome":[185,369],"resistance":[186,454,510],"AR-targeted":[188],"therapies.":[189],"METHODS:":[190],"We":[191,445],"used":[192],"purified":[193],"epithelial":[194,471],"(22Pc-EP)":[195],"fibroblast":[197,486],"(22Pc-CAF)":[198],"lines":[200],"patient-derived":[203],"xenograft":[204],"model":[205],"(CWR22Pc),":[206],"initially":[209],"castration":[210,216],"sensitive":[211,380,386,523],"but":[212,389],"progress":[214],"resistant.":[217],"The":[218],"22Pc-EP":[219,338],"line":[220,473],"endogenous":[222],"PTEN":[223,227,351,430,437,459,535,539],"wild-type":[224,431,438,460,536,540],"(22Pc-EPWT)":[225],"knock-out":[228,433],"(22Pc-EPPTEN)":[230],"were":[231,236,250,274,284,314,355,384,440,517],"generated":[232],"using":[233],"CRISPR-Cas9.":[234],"Cells":[235],"stimulated":[237],"either":[239,299],"recombinant":[240,327,414,478],"or":[242,305,597],"conditioned":[243,408,487],"media":[244,409],"from":[246],"22Pc-CAFs.":[248],"Lysates":[249],"prepared":[251],"for":[252,258,321,549],"western":[253],"blot":[254],"analysis":[255],"assess":[257],"downstream":[261,333,465],"cascades,":[263],"without":[267],"enzalutamide":[270,358,379,422],"Growth":[272],"assays":[273],"also":[275,385],"performed":[276],"under":[277],"similar":[278],"conditions.":[279],"22Pc-EPWT":[280,353],"22Pc-EPPTEN":[282,382],"co-injected":[285],"subcutaneously":[286],"(10:1":[287],"ratio)":[288],"flanks":[291],"castrated":[293],"male":[294],"mice":[295],"then":[296],"treated":[297],"vehicle":[300],"control,":[301],"castration+enzalutamide":[302],"(30":[303],"mg/kg/day),":[304],"enzalutmide+zenocutuzumab":[306],"(25":[307],"mg/kg":[308],"intraperitoneal":[309],"injection":[310],"weekly)":[311],"once":[312],"tumors":[313,439],"established.":[315],"Tumor":[316],"volume":[317],"was":[318,329,344,362,368,401,474,558],"measured":[319],"bi-weekly":[320],"7":[322],"weeks.":[323],"RESULTS:":[324],"Stimulation":[325],"able":[330,518],"activate":[332],"PI3K":[334,512],"lines,":[340],"signal":[343],"more":[345],"robust":[346],"setting":[349],"loss.":[352],"responsive":[356,441],"decreased":[363,393,424],"upon":[364],"treatment,":[365],"though":[366],"stimulation":[371,391,480],"NRG.":[373],"Treatment":[374],"restored":[377],"phenotype.":[381],"enzalutamide,":[388],"paradoxically":[392],"no":[397],"observed.":[402],"Culturing":[403],"22Pc-CAF":[407],"conferred":[410],"analogous":[411],"results":[412],"stimulation.":[416],"In":[417],"our":[418],"experiment,":[421],"significantly":[423],"setting.":[434,537],"However,":[435],"only":[436],"zenocutuzumab.":[443],"CONCLUSIONS:":[444],"survival":[452],"cells.":[462],"Activation":[463],"seen":[475],"after":[476],"culturing":[482],"associated":[485],"media.":[488],"This":[489,556],"supports":[490],"paracrine":[492],"action":[494],"whereby":[497],"it":[498],"secreted":[500],"stromal":[502],"promote":[509],"signaling.":[513],"Using":[514],"zenocutuzumab,":[515],"restore":[520],"an":[521,546],"androgen":[522],"phenotype":[524],"High-risk":[538],"cancers":[542],"may":[543],"therefore":[544],"be":[545],"appropriate":[547],"population":[548],"future":[550],"studies.":[552],"Source":[553],"Funding:":[555],"funded":[559],"Conquer":[562,598],"Cancer":[563],"\u2013":[564],"GlaxoSmithKline":[565],"Oncology":[566],"Young":[567],"Investigator":[568],"Award.":[569],"Any":[570],"opinions,":[571],"findings,":[572],"conclusions":[574],"expressed":[575],"material":[578],"are":[579],"those":[580,589],"author(s)":[583],"do":[585],"not":[586],"necessarily":[587],"reflect":[588],"American":[592,603,621],"Society":[593],"Clinical":[595],"Oncology\u00ae":[596],"Cancer\u00ae":[599],"\u00a9":[600],"2024":[601,619],"Urological":[604,622],"Association":[605,623],"Education":[606,624],"Research,":[608,626],"Inc.FiguresReferencesRelatedDetails":[609],"Volume":[610],"211Issue":[611],"5SMay":[612],"2024Page:":[613],"e182":[614],"Advertisement":[615,669],"Copyright":[616],"Permissions\u00a9":[618],"Inc.Metrics":[627],"Information":[629],"More":[632,639,646,654,662],"articles":[633,640,647,655,663],"author":[636,643,650,658,666],"Expand":[667],"PDF":[670],"downloadLoading":[671],"...":[672]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2024-04-16T00:00:00"}